Zealand Pharma A/S
ZLDPF
$65.16
$1.802.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.95% | 7.07% | -26.88% | 12.89% | -452.98% |
| Total Depreciation and Amortization | -44.45% | -6.51% | 1.27% | 88.46% | -16.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -123.67% | -142.32% | 263.28% | -77.60% | 476.10% |
| Change in Net Operating Assets | 902.08% | -283.51% | 296.06% | -101.75% | 247.72% |
| Cash from Operations | 40.73% | -30.38% | -2.49% | -479.06% | 152.20% |
| Capital Expenditure | -353.10% | 94.95% | -42.97% | 47.00% | -694.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.43% | -24,390.43% | 98.17% | -10,436.05% | -91.76% |
| Cash from Investing | 102.41% | -20,290.95% | 97.81% | -20,858.41% | -95.87% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -9.71% | -9.42% | 0.93% | 55.31% | -221.50% |
| Issuance of Common Stock | -98.41% | -99.93% | 376.13% | 9,882.07% | 120.55% |
| Repurchase of Common Stock | 100.00% | -234.20% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.76% | 98.88% | -820.22% | -3,822.74% | -- |
| Cash from Financing | 98.36% | -104.12% | 266.86% | 32,722.22% | 37.25% |
| Foreign Exchange rate Adjustments | 279.56% | -311.29% | -74.14% | 152.63% | -230.33% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -- |
| Net Change in Cash | 99.55% | -204.67% | 2,779.79% | 246.85% | 12.99% |